An introduction to the potential of 1H-, 31P- and 13C-NMR-spectroscopy

Anticancer Research

Volumn 16, Issue 3 B, 1996, Pages 1317-1324

  Leibfritz, D ^a  

^a UNIVERSITY OF BREMEN   (Germany)

Author keywords

13C ; 1H ; 31P NMR spectroscopy; Animal models; Biochemical pathways; Biopsies; Body fluids; Cells; Pattern recognition

Indexed keywords

BIOCHEMICAL MARKER; CREATINE PHOSPHATE; GLUCOSE; LACTIC ACID;

ANALYTIC METHOD; ANIMAL TISSUE; BIOPSY; BODY FLUID; CARBON NUCLEAR MAGNETIC RESONANCE; CELL PH; CONFERENCE PAPER; CONTROLLED STUDY; GLIOMA; INTRACELLULAR FLUID; LIPID ANALYSIS; NONHUMAN; PATTERN RECOGNITION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; TUMOR BIOPSY; TUMOR CELL; ANIMAL; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION; REVIEW;

ANIMALS; BIOPSY; BODY FLUIDS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION;

EID: 0029666217     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Nicholson JK, Wilson ID: High resolution proton magnetic resonance spectroscopy of biological fluids. Progr in NMR Spectr 21: 444-501, 1989.
2. 1H-NMR spectra of human blood plasma. Progr in NMR Spectr 27: 475-554, 1995.
3. Bell JD: NMR studies of body fluids and drug metabolism: An overview: p 7-32, in "MRS in Biofluids" (Ed. J. D. de Certaines) World Scientific Press (1989).
4. Kaplan O, van Zijl PCM, Cohen JS: NMR studies of metabolism of cells and perfused organs Vol 28, 3-54 in "NMR" (Ed.: P. Diehl, E. Flurk, H. Gunther, R. Kosfeld, J. Seelig), Springer Verlag Berlin 1992.
5. Czuba M, Smith ICP: Biological and NMR markers for cancer. Pharmacol Therap 50: 147-190, 1991.
6. Henke J, Willker W, Engelmann J, Leihfritz D: Combined extraction techniques of tumour cells and lipid/phospholipid assignment by two dimensional NMR spectroscopy. Anticancer Res 16: 1417-1428, 1996.
7. 1H-NMR spectra by pattern recognition. NMR in Biomed 5: 59-64, 1992.
8. 1H-NMR spectra. J Microcomp.Appl 16: 113-123, 1993.
9. Pao YH: Adaptive pattern recognition and neural networks. Addison-Wesley Publishing Comp. Meneo Park, USA 1989.
10. Griffiths JR, Howells SL, Tate AR: Lipid metabolite peaks in pattern recognition analysis of tumour MR spectra. Anticancer Res 16: 1575-1580, 1996.
11. 13C-NMR study on fluxes into the Krebs cycle of rabbit renal proximal tubular cells. NMR in Biomed 1: 171-176, 1989.
12. 13C-NMR-spectroscopy. Dev Neurosci 1995 in press.
13. Engelmann J et al: Early stage monitoring of miltefosine induced apoptosis in KB cells by multinuclear NMR spectroscopy: Anticancer Res 16; 1429-1440, 1996.
14. Katz-Brull R, Degans H: Kinetics and choline transport and phosphorylation in human breast cancer cells. NMR applications of the Zero Trans Method. Anticancer Res 16: 1375-1380, 1996.
15. Ting YLT. Sherr D, Degani H: Variation in the energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res 16: 1381-1388, 1996.
16. Podo F, Ferreti A et al: Detection of phosphatidylcholine-specific phospholipase C in 3T3 fibroblasts and their ras transformants. NMR and immunochemical studies. Anticancer Res 16: 1399-1412, 1996.
17. 31P-MRS of human tumour cells: effects of culture media and conditions on phospholipid metabolite concentrations; Anticancer Res 16: 1365-1374, 1996.
18. Aiken NR, Gillies RG: Phosphomonoester metabolism as a function of cell proliferative status; Anticancer Res 16: 1393-1398, 1996.
19. 13C NMR study. Anticancer Res 16: 1351-1356, 1996.
20. Smith TAD, Eccles S, Box G, Titley JC, Leach MO, McCready VR: Phosphocholine and choline content of rat sarcomas cells grown in the presence and absence of serum; Anticancer Res 16: 1389-1392, 1996.
21. Degani H: NMR in Biomedicine, 1996, in press.
22. Neeman M, Degani H: Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy; Cancer Res 49: 589-594, 1989.
23. Cohen JS, Lyon RC, Daly PF: Monitoring of intracellular metabolism by nuclear magnetic resonance. Methods in Enzymol 177: 435-452, 1989.
24. 31P-NMR. Magn Res Med 18: 181, 1991.
25. Szwergold BS: NMR spectroscopy of cells. Ann Rev Physiol 54: 775-798, 1992.
26. 19F-NMR of fluorine labelled chelators. Proc Natl Acad Sci USA 80: 7178-7182, 1983.
27. van Zijl PCM, Moonen CTW, Faustino P: Complete separation of intracellular and extracellular information in NMR spectra of perfused cells by diffusion weighted spectroscopy. Proc Natl Acad Sci USA 88: 3228-3232, 1991.
28. Flogel U, Niendorf T, Benters J, Leibfritz D: Perfused brain cells embedded in basement membrane gel threads: an experimental model to monitor transient ischemia and subsequent recovery. Int Soc Magn Res Med 1995: 1775, Nice, France.
29. Mountford C et al: Human cancers detected by MR spectroscopy and che-mical shift imaging ex vivo. Anticancer Res 16: 1521-1533, 1996.
30. 1H-MRS of colon tissue. Anticancer Res 16: 1553-1558, 1996.
31. Kuesel AC et al: Mobile lipid accumulation in necrotic tissue of high grade astrocytomas. Anticancer Res 16: 1485-1490, 1996.
32. Frahm J, Merbold KD, Hanicke W: Localized proton spectroscopy using stimulated echos. J Mag Res 72: 502-508, 1987.
33. Gordon RE, Ordige RJ: Volume selection for high resolution NMR studies. Proc Soc Magn Med 3rd Ann Meeting, New York, 1984, 272-273.
34. Brown TR, Kincaid BM, Ugurbil K: NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 79: 3523-3526, 1982.
35. Dreher W, Leibfritz D et al: Characterization of implanted gliomas in rat brain by high resolution proton spectroscopic imaging, NMR imaging and histological examinations. Proc Soc Magn Res Med Ann Meeting 1993, 16, New York.
36. Kühn B, Dreher W, Norris D, Leibfritz D: Fast proton spectroscopic imaging employing k-space weighting achieved by variable repetition times; Magn Res Med 34, in press (1996)
37. Dreher W, Leibfritz D: On the use of two-dimensional J-NMR measurements for in vivo proton MRS: Measurement of homonuclear decoupled spectra without the need for short echo times. Magn Res Med 34: 331-337, 1995.
38. 13C NMR study on fluxes into the TCA cycle of neuronal and glial cells. Biochimie 74: 941-948, 1992.
39. Leach MO: Introduction to in vivo MRS of cancer: New perspectives and open problems; Anticancer Res 16: 1503-1514, 1996.